Excessive Supraventricular Ectopies or Short Atrial Runs
📧 Sign up to get email alerts when something new happens for Excessive Supraventricular Ectopies or Short Atrial Runs.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk [Phase 4]
A Phase 4 clinical trial comparing rivaroxaban to standard of care in patients with Excessive Supraventricular Ectopies or Short Atrial Runs…